Investing & Analysis Articles

This Is Like Getting the Chance to Buy Apple and IBM When They Were Newly Public

I was just talking to a trusted friend and source, economist and ex-professional musician, Jeff Scot. Scot has been warning for a long time that the big subprime-burdened banks were at risk. READ MORE

A Therapy That Will Save the U.S. Economy Hundreds of Billions of Dollars and Add Years to Average Life Spans

This is an extraordinary time to be an investor. As you know, this newsletter doesn't typically think short run. We don't pay attention to the irrational fluctuations driven by market psychology. READ MORE

A Company With a Core Team That Increased Value 100,000% in 7 Years

Since my last weekly alert, Hurricane Ike passed Florida to wreak havoc in Texas. One of the odd characteristics of living in Florida, especially South Florida, is a regular and vague sense of guilt for hoping storms hit somebody else. READ MORE

Intel CTO Predicts Huge Robot Growth

Intel's CTO was obviously not talking about the growth of huge robots, as the headline above might imply. I do like the giant robot image, though. READ MORE

New Nuclear Technologies Could Yield Spectacular Profits

It's been another remarkable week. On top of startling science and technology news, there have been major distractions in the forms of hurricanes and politics. READ MORE

New Stem Cell Patent Leader Emerges, and You Already Own It

When I recommended the company, it had just acquired Advanced Cell Technology's "shotgun" stem cell platform. This breakthrough automated system determines how stem cells are programmed into specific therapeutic applications. READ MORE

Uranium From Seawater Offers Extraordinary Profits

Good day. I'm writing this weekly alert on Sunday because the National Hurricane Center has issued a hurricane watch for the southwest coast of Florida. About half the computer models today have Fay coming ashore near Marco Island, where I live. READ MORE

The Real Alzheimer’s Cure Will Earn Billions

I'd like to talk today about some recent news stories that relate to Anavex Life Sciences Corp. (AVXL: OTCBB), the sigma receptor company in our portfolio. I'm also going to tell you the worst thing about my job. READ MORE

Satellite Radio Old Idea; New Tech Opportunities Closer to Ground

One is the persistent pessimism I'm seeing in both the media and the polls. I just looked at Gallup's daily numbers, and the phenomenon is clear. More than three-quarters of Americans believe we are in some sort of recession. READ MORE

Myostatin Inhibitors Will Break Pharmaceutical Profit Records

I'd like to tell you about a couple of important new breakthroughs that have just shown up on the radar. Both have enormous potential in terms of both your health and your portfolio. READ MORE

Regulatory Crisis in Stem Cell Industry Presents Opportunities

I'm sending this out on a weekend because I to make sure you have a change to prepare before the market opens Monday morning. We need to sell Advanced Cell Technology, Inc. (OTCBB:ACTC) READ MORE

There Has Never Been a Better Time to Be an Investor

Let me explain. First, of course, I have to acknowledge that the financial media are vacillating between panic and despair. The bill is finally coming due for two of the most incredibly stupid policies in modern history. READ MORE

Moore’s Law Will Continue Growing Millionaires

For reasons I explained in the letter, the stock went up immediately. The biggest upward influence was the information presented by Anavex scientists at the Alzheimer's Association International Conference in Chicago last week. READ MORE

Salmonella Outbreak Promises Huge Profits for Nanotech Investors

It's great to be writing to you again. I hope everything is well with you. It's hard to get a handle on the latest salmonella outbreak. Certainly, the FDA hasn't figured out where the toxin is coming from. READ MORE

Transformational Companies Earn Wal-Mart-Sized Profits

In March, I put China Direct Inc. (CDS: NASDAQ) on our buy list. Since then, it's been increasing in value nicely. The company has scored a number of successes and, at one point, doubled in price. READ MORE

Two Companies Set to Grow Profits Tens of Thousands of Percent

I've had several interesting messages from readers recently. The most gratifying came from Dr. Tom Schmidt, who runs the doctoral-level information technology program for a major university. READ MORE

IEEE Takes on Singularity Issue

Another remarkable week has come and passed. You know that the pace of technological change is increasing. Even as a professional tech watcher, however, I'm surprised how fast things have been developing of late. READ MORE

Alnylam on Course for Huge, Disruptive Profits

It's a great time to be an investor. I've got terrific news about Alnylam Pharmaceuticals (ALNY: NASDAQ). Alnylam was my first stock pick back in January, when I took on this charter. READ MORE

Tapping Mobile Phone Profits

I've just finished this month's newsletter. We are is preparing it now, so you'll have the electronic version soon. The "dead tree" version will follow shortly after. READ MORE

Alnylam/MIT Breakthrough Moves RNAi Therapies Closer by Years

The scientific journal Nature Biotechnology just published the results of a study conducted by researchers from Alnylam Pharmaceuticals Inc. (ALNY: NASDAQ) and MIT. READ MORE